"Performing world class translational research to bring diagnosis, care and therapy to people with neuromuscular disease."

During the past decade, John Walton Muscular Dystrophy Research Centre conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "John Walton Muscular Dystrophy Research Centre" #1 collaborator was "Adult SMA REACH" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "SMA REACH UK" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "John Walton Muscular Dystrophy Research Centre" are "Facioscapulohumeral Muscular Dystrophy" (1 trials), "GNE Myopathy" (1 trials), "Hereditary Inclusion Body Myopathy" (1 trials), "Myotonic Dystrophy" (1 trials) and "SMA" (1 trials). Many other conditions were trialed in "John Walton Muscular Dystrophy Research Centre" in a lesser frequency.

Most popular intervention types in "John Walton Muscular Dystrophy Research Centre" are "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Patient Registry" (4 trials). Other intervention names were less common.

The vast majority of trials in "John Walton Muscular Dystrophy Research Centre" are 4 trials for "All" genders.

Currently, there are NaN active trials in "John Walton Muscular Dystrophy Research Centre". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in John Walton Muscular Dystrophy Research Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in John Walton Muscular Dystrophy Research Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".